Recipharm has named Richard Turner as head of business development, and Jeremy Tidmarsh as Site Director, Holmes Chapel, to its Advanced Delivery Systems business unit, as it the global CDMO continues to step up its ambition to supply low global warming potential (GWP) pressurised Metered Dose Inhalers (pMDIs) in response to customer demand. Recipharm had unveiled a link up with Honeywell to speed up the development of inhalers with a near-zero GWP propellant, Honeywell Solstice Air.